Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.87

-1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Abuckatatime who wrote (10108)	10/27/1997 9:10:00 AM
From: Henry Niman	Read Replies (1) of 32384

Today's thestreet.com has an article on SEQU (also by Jesse Eisinger). They were up on Friday on a down day because of earnings. Their liposome encapsulated drug for KS showed increased sales in spite of a shrinking KS population, because of MDs willingness to use it off-label for other cancer indications. A similar situation should arise for Targretin and Panretin. As long as there is some clinical data (and LGND should have Phase II data for a variety of indications for both compounds by the time they are approved for KS or CTCL), MDs are prescribing.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next